Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Di Biagio and Stefano Rusconi.
Connection Strength
1.393
-
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The "ImpACT-COVID-19 for Patients" Multi-Centre Observational Study. Int J Environ Res Public Health. 2021 01 05; 18(1).
Score: 0.231
-
Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020 11 01; 34(13):1983-1985.
Score: 0.228
-
A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice. AIDS Rev. 2018 Apr-Jun; 20(2):75-82.
Score: 0.190
-
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience. J Women Aging. 2019 Mar-Apr; 31(2):176-188.
Score: 0.188
-
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation. AIDS Patient Care STDS. 2017 Dec; 31(12):487-494.
Score: 0.186
-
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting. J Antimicrob Chemother. 2019 05 01; 74(5):1363-1367.
Score: 0.051
-
Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. Ann Pharmacother. 2018 08; 52(8):740-746.
Score: 0.047
-
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. PLoS One. 2017; 12(11):e0187393.
Score: 0.046
-
Weight Gain: A Possible Side Effect of All Antiretrovirals. Open Forum Infect Dis. 2017; 4(4):ofx239.
Score: 0.046
-
Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 08 09; 17(1):551.
Score: 0.046
-
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. PLoS One. 2017; 12(6):e0179254.
Score: 0.045
-
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA =50 cp/mL. Infection. 2017 Aug; 45(4):521-528.
Score: 0.045
-
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr; 40(2):139-142.
Score: 0.044